BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7157557)

  • 1. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine in management of large pituitary tumours.
    Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
    Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of pituitary adenomas.
    Baskin DS; Wilson CB
    Neurosurgery; 1981 Jun; 8(6):741-4. PubMed ID: 7279165
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
    Lundberg PO; Bergström K; Thuomas KA; Muhr C; Enoksson P
    Acta Radiol Suppl; 1986; 369():310-3. PubMed ID: 2980483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
    Woodhouse NJ; Khouqueer F; Sieck JO
    Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gonadotropic pituitary adenoma and pregnancy. Value of bromocriptine].
    Robert M; Leriche-Polverelli A; Hamon P; Labat-Moleur F; Tourniaire J
    Presse Med; 1991 Mar; 20(11):503-6. PubMed ID: 1827188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
    Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
    Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M; Ventz M; Meng W
    Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia in males with and without pituitary macroadenomas.
    Spark RF; Wills CA; O'Reilly G; Ransil BJ; Bergland R
    Lancet; 1982 Jul; 2(8290):129-32. PubMed ID: 6123841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia.
    Grossman A; Bouloux PM; Loneragan R; Rees LH; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1985 May; 22(5):611-6. PubMed ID: 4028459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia in men-response to bromocriptine therapy.
    Prescott RW; Johnston DG; Kendall-Taylor P; Crombie A; Hall K; McGregor A; Hall R
    Lancet; 1982 Jan; 1(8266):245-8. PubMed ID: 6120274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.